Leon Nanodrugs

Planegg, Germany · Founded 2010 · Privately Held (backing)

Developer of drugs through nanoscience designed to offer patient outcomes. Leon Nanodrugs is based in Planegg, Germany and was founded in 2010. Its last reported valuation was $71 million in Jul 2015. It has raised $20.5 million.

Last reported valuation
$71.0M
Oct 2026
Priced at
—
Total raised
$20.5M
Last round
—

Who backs Leon Nanodrugs?

11 investors
InvestorType
LBBW Venture CapitalOther
Albany Capital (Australia)—
Albany Private Equity Holding—
Bayerische Beteiligungsgesellschaft—
CB one Holding—
CD-Venture—
Eckenstein-Geigy-Stiftung—
Evotec—
LifeCare Partners—
Signet Healthcare Partners—
+ 1 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Leon Nanodrugs investors

11 investors are on record for Leon Nanodrugs, including LBBW Venture Capital, Albany Capital (Australia), Albany Private Equity Holding and Bayerische Beteiligungsgesellschaft.

Free account
More of Leon Nanodrugs with a free account
  • ·The complete investor list: 11 names
  • ·Watch Leon Nanodrugs: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 11 firms already write checks for companies like Leon Nanodrugs. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View